Published in Cytotechnology on January 01, 1993
Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol (2014) 0.99
Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest (1994) 0.76
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med (1987) 5.57
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis (2001) 3.16
Conserved major histocompatibility complex class II boxes--X and Y--are transcriptional control elements and specifically bind nuclear proteins. Proc Natl Acad Sci U S A (1987) 2.55
Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell (1992) 2.50
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev (1995) 2.33
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. J Virol (1989) 2.20
Compartmentalization of MHC class II gene expression in transgenic mice. Cell (1988) 2.08
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 2.06
Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med (1989) 1.90
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification. Mol Cell Biol (2004) 1.87
Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. Nature (1985) 1.87
Spoligotype diversity of Mycobacterium bovis strains isolated in France from 1979 to 2000. J Clin Microbiol (2001) 1.82
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71
Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts. Proc Natl Acad Sci U S A (1983) 1.68
RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol (1994) 1.66
Anemia of end-stage renal disease (ESRD). Kidney Int (1985) 1.63
The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol (1995) 1.61
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci U S A (1994) 1.59
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis (1990) 1.57
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest (1978) 1.53
Longitudinal ruptures of polyester knitted vascular prostheses. J Vasc Surg (2001) 1.52
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Molecular typing of Mycobacterium bovis isolates from Cameroon. J Clin Microbiol (2001) 1.50
The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation. Blood (1968) 1.48
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol (1993) 1.46
Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.46
Palmitylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J Biol Chem (1989) 1.45
Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest (1987) 1.45
[Analogs of abscisic acid (plus or minus) dormancy hormone. Structure-activity relations]. C R Acad Sci Hebd Seances Acad Sci D (1970) 1.45
The anemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood (1975) 1.40
The pathogenesis of myeloproliferative syndromes. Br J Haematol (1978) 1.39
The kidney and erythropoiesis. Am J Med (1968) 1.39
Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition. J Clin Invest (1986) 1.39
Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38
Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol (1989) 1.37
Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35
Role of signal recognition particle in the membrane assembly of Sindbis viral glycoproteins. Eur J Biochem (1984) 1.34
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med (1987) 1.32
Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol (1987) 1.30
Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res (1990) 1.30
Free diffusion to and from the inner nuclear membrane of newly synthesized plasma membrane glycoproteins. J Cell Biol (1987) 1.27
Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. J Clin Invest (1988) 1.27
Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood (1981) 1.26
Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver. Proc Natl Acad Sci U S A (1984) 1.24
Erythrocytosis associated with hemoglobin Rainier: oxygen equilibria and marrow regulation. J Clin Invest (1969) 1.23
Characteristics of murine megakaryocytic colonies in vitro. Blood (1979) 1.22
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J Biol Chem (1994) 1.21
A deficiency in RFX3 causes hydrocephalus associated with abnormal differentiation of ependymal cells. Eur J Neurosci (2006) 1.21
Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res (1999) 1.20
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Contrib Nephrol (1989) 1.20
Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci U S A (1991) 1.19
Biochemical fractionation and assembly of the membrane components that mediate nascent chain targeting and translocation. Cell (1991) 1.18
In vitro study of the NS2-3 protease of hepatitis C virus. J Virol (1997) 1.18
Oligodendrocyte precursor cells count time but not cell divisions before differentiation. Curr Biol (1997) 1.16
Pure and functionally homogeneous recombinant retinoid X receptor. J Biol Chem (1994) 1.15
Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood (2000) 1.14
Cell number control and timing in animal development: the oligodendrocyte cell lineage. Int J Dev Biol (1998) 1.14
Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proc Natl Acad Sci U S A (1988) 1.13
Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J Immunol (1995) 1.13
Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A (1991) 1.12
Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis (1988) 1.12
Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl (1982) 1.11
The influence of thyroid hormones on in vitro erythropoiesis. Mediation by a receptor with beta adrenergic properties. J Clin Invest (1977) 1.10
Structural vulnerability of the French swine industry trade network to the spread of infectious diseases. Animal (2012) 1.08
Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol (1984) 1.07
Molecular differentiation of Mycobacterium bovis isolates. Review of main techniques and applications. Res Vet Sci (2004) 1.06
The cellular retinoic acid binding protein I is dispensable. Proc Natl Acad Sci U S A (1994) 1.05
Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships. J Cell Physiol (1976) 1.05
Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood (1992) 1.03
In vivo expansion of purified hematopoietic stem cells transplanted in nonablated W/Wv mice. Exp Hematol (1999) 1.03
Human erythroid colony formation in vitro: evidence for clonal origin. J Cell Physiol (1976) 1.03
Patterns of lesions of bovine tuberculosis in wild red deer and wild boar. Vet Rec (2008) 1.02
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest (1984) 1.02
Hemoglobin function, oxygen affinity, and erythropoietin. Annu Rev Physiol (1975) 1.01
Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis (1989) 1.01
An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Dev Biol (1999) 1.01
Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues. J Cell Biol (1992) 1.00
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest (1977) 1.00
Development of humanized mice for the study of hepatitis C virus infection. Transplant Proc (2006) 1.00
Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol (1986) 0.99
The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol (1991) 0.99
Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. J Clin Invest (1984) 0.99
Biosynthesis and oligosaccharide structure of human CD8 glycoprotein expressed in a rat epithelial cell line. J Biol Chem (1992) 0.99
Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest (1979) 0.98
Modulation of in vitro erythropoiesis: enhancement of erythroid colony growth by cyclic nucleotides. Cell Tissue Kinet (1977) 0.97